| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $98.0M | +3.7% |
| SG&A Expense | $33.2M | +6.7% |
| Operating Income | -$131.2M | -4.4% |
| Pre-tax Income | -$124.1M | -0.3% |
| Income Tax | $0 | — |
| Net Income | -$124.1M | -0.3% |
| EPS (Basic) | -$1.68 | +39.1% |
| EPS (Diluted) | -$1.68 | +39.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.7M | -52.1% |
| Short-term Investments | $59.0M | -35.4% |
| Current Assets | $111.6M | -42.4% |
| Total Assets | $170.5M | -38.9% |
| Current Liabilities | $22.7M | -6.2% |
| Total Liabilities | $31.1M | -12.6% |
| Stockholders' Equity | $139.4M | -42.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$102.1M | +2.3% |
| Capital Expenditures | $1.2M | -94.0% |
| Investing Cash Flow | $48.7M | -41.8% |
| Financing Cash Flow | $4.0M | -94.8% |
| Free Cash Flow | -$103.3M | +17.4% |